Healthcare provider profile · identity verified

Bonnie E Nowak, MD

Internal Medicine · FORT COLLINS, CO · NPI 1326049016

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	988	238
Atorvastatin Calcium	Atorvastatin Calcium	657	179
Losartan Potassium	Losartan Potassium	559	164
Omeprazole	Omeprazole	423	130
Rosuvastatin Calcium	Rosuvastatin Calcium	404	125
Gabapentin	Gabapentin	376	110
Amlodipine Besylate	Amlodipine Besylate	365	102
Lisinopril	Lisinopril	269	82
Trazodone Hcl	Trazodone Hcl	257	73
Potassium Chloride	Potassium Chloride	245	77
Duloxetine Hcl	Duloxetine Hcl	212	59
Simvastatin	Simvastatin	195	49
Hydrochlorothiazide	Hydrochlorothiazide	183	52
Metoprolol Succinate	Metoprolol Succinate	178	51
Carvedilol	Carvedilol	169	50
Metformin Hcl Er	Metformin Hcl	144	37
Ozempic	Semaglutide	143	24
Furosemide	Furosemide	136	49
Pantoprazole Sodium	Pantoprazole Sodium	136	39
Meloxicam	Meloxicam	131	48
Montelukast Sodium	Montelukast Sodium	130	35
Escitalopram Oxalate	Escitalopram Oxalate	123	44
Metformin Hcl	Metformin Hcl	118	39
Citalopram Hbr	Citalopram Hydrobromide	115	34
Estradiol	Estradiol	114	52
Tamsulosin Hcl	Tamsulosin Hcl	108	27
Alendronate Sodium	Alendronate Sodium	105	31
Eliquis	Apixaban	104	26
Synthroid	Levothyroxine Sodium	101	27
Donepezil Hcl	Donepezil Hcl	100	26
Sertraline Hcl	Sertraline Hcl	100	31
Spironolactone	Spironolactone	95	26
Memantine Hcl	Memantine Hcl	91	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	89	22
Albuterol Sulfate Hfa	Albuterol Sulfate	88	37
Allopurinol	Allopurinol	85	23
Pregabalin	Pregabalin	83	22
Fluoxetine Hcl	Fluoxetine Hcl	75	18
Venlafaxine Hcl Er	Venlafaxine Hcl	74	17
Ezetimibe	Ezetimibe	73	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	19
Metoprolol Tartrate	Metoprolol Tartrate	67	21
Bupropion Xl	Bupropion Hcl	62	23
Pravastatin Sodium	Pravastatin Sodium	61	19
Clopidogrel	Clopidogrel Bisulfate	59	18
Tramadol Hcl	Tramadol Hcl	59	21
Lorazepam	Lorazepam	58	suppressed
Jardiance	Empagliflozin	56	18
Mirtazapine	Mirtazapine	56	22
Atenolol	Atenolol	54	14
Valacyclovir	Valacyclovir Hcl	54	22
Glipizide Er	Glipizide	53	14
Irbesartan	Irbesartan	53	18
Xarelto	Rivaroxaban	51	13
Famotidine	Famotidine	50	21
Prednisone	Prednisone	47	31
Zolpidem Tartrate	Zolpidem Tartrate	46	14
Ipratropium Bromide	Ipratropium Bromide	44	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	11
Alprazolam	Alprazolam	42	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	42	16
Doxycycline Hyclate	Doxycycline Hyclate	42	32
Diclofenac Sodium	Diclofenac Sodium	41	12
Quetiapine Fumarate	Quetiapine Fumarate	41	11
Celecoxib	Celecoxib	39	11
Fluticasone Propionate	Fluticasone Propionate	38	14
Solifenacin Succinate	Solifenacin Succinate	38	13
Lovastatin	Lovastatin	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	11
Linzess	Linaclotide	36	suppressed
Propranolol Hcl	Propranolol Hcl	36	12
Rybelsus	Semaglutide	35	suppressed
Bumetanide	Bumetanide	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Cefuroxime	Cefuroxime Axetil	32	30
Ibandronate Sodium	Ibandronate Sodium	32	suppressed
Methylprednisolone	Methylprednisolone	32	24
Trulicity	Dulaglutide	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	29	suppressed
Finasteride	Finasteride	29	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Ondansetron Odt	Ondansetron	29	15
Bupropion Hcl Sr	Bupropion Hcl	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Acyclovir	Acyclovir	26	13
Chlorthalidone	Chlorthalidone	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	24
Buspirone Hcl	Buspirone Hcl	25	suppressed
Baclofen	Baclofen	24	suppressed
Belsomra	Suvorexant	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	16
Topiramate	Topiramate	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Dutasteride	Dutasteride	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Nystatin	Nystatin	19	12
Colchicine	Colchicine	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Warfarin Sodium	Warfarin Sodium	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	13
Cephalexin	Cephalexin	17	11
Enalapril Maleate	Enalapril Maleate	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Ramipril	Ramipril	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Xtampza Er	Oxycodone Myristate	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	11
Fluconazole	Fluconazole	14	12
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Primidone	Primidone	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Estradiol (Twice Weekly)	Estradiol	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Pulmicort Flexhaler	Budesonide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clonazepam	Clonazepam	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error